How will the Indian Pharma Market Shape Up?

July 25, 2020

While there is a big buzz around digital adoption by Indian Pharma, necessitated by the disruption brought about by Covid-19, it is also a good time to discuss the future of Indian Pharma market and how it is likely to shape up.

This article by Rajeev Kumar was published in the April 2018 issue of MedicinMan. It will be great to listen to the perspectives of Indian Pharma leaders. Do share your thoughts here about the challenges, opportunities and the future of Indian Pharma.

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Topics

Not Digital Solutions alone, but Business Solutions that add Value to Customers delivered via Digital Platforms

Digital Therapeutics: New Frontiers in Healthcare

How will the Indian Pharma Market Shape Up?

Free Membership Required

Why Is the World’s Pharmacy Failing to Protect Patients from Harm?

Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.

The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?

10 Years of Pharma M&A — Who’s Really Benefited?

What’s Killing Patients? Cancer or Rigged Drug Prices?

Topics

Why Is the World’s Pharmacy Failing to Protect Patients from Harm?

Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.

The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?

10 Years of Pharma M&A — Who’s Really Benefited?

What’s Killing Patients? Cancer or Rigged Drug Prices?

A Tale of Two Cities: Peptides and Prescriptions

Trust Is Pharma’s Fulcrum: Are We Getting the Basics Right?

The $1.5 Billion Question in Hyderabad: Orbicular, Peptides and the PE Re-Rating of Indian Complex Generics

Related Articles

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

RPG-Raghava and Lessons From a Decade of Indian Pharma M&A

Why The Government Must Stop Playing Market Trader And Start Being The Sheriff

GLP-1: When the Molecule Becomes a Commodity, What Becomes the Moat?

Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?

Company

Headlines

Why Is the World’s Pharmacy Failing to Protect Patients from Harm?

Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.

The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?

10 Years of Pharma M&A — Who’s Really Benefited?

Newsletter